FDA Requesting Public Input on Tobacco Product Advertising and Promotion
Monday, July 12, 2010
To help it successfully implement the provisions of the Family Smoking Prevention and Tobacco Control Act, the FDA is seeking public input on tobacco product advertising and promotion to racial and ethnic minority populations, including the promotion of menthol to youth.
Written or electronic comments must be submitted by July 26, 2010.
This is an important opportunity for you to provide FDA with concrete examples of advertising and promotion of menthol and other cigarettes to youth in your communities. Documenting the amount and types of this type of advertising will help the agency understand the scope of the problem and develop a strong action plan to address it. Below are a few examples of the types of information that the FDA can only get from those of you working on the front lines of tobacco control. In addition to written comments, you can also submit photos. If you do submit photos, please include the location and date that the photo was taken.
It will be important for the FDA to have as much information as possible on the following:
- Examples of tobacco marketing to specific racial and ethnic minority populations
- Examples of the tobacco marketing appearing in minority neighborhoods
- Examples of marketing near schools and playgrounds, especially outdoor marketing
- Examples of marketing in the retail environment – at point-of-sale
- Examples of marketing of menthol products
The public docket is currently open:
NAME: Tobacco Product Advertising and Promotion to Youth and Racial and Ethnic Minority Populations; Request for Comments
ACTION: Notice; request for data and information
DOCKET NUMBER: FDA–2010–N–0207
CLOSE DATE: Monday, July 26
Submit comments online at: www.regulations.gov
Submit comment by mail to:
Division of Dockets Management (HFA-305)
Food and Drug Administration
5630 Fishers Lane, Room 1061
Rockville, MD 20852.
For additional information on this specific request for comments, contact Kathleen K. Quinn at 240-276-1717 or kathleen.quinn@fda.hhs.gov.
|
|
Email to a Friend